Mutations within a human IgG2 antibody form distinct and homogeneous disulfide isomers but do not affect Fc gamma receptor or C1q binding |
| |
Authors: | Sandra Lightle Serdar Aykent Nathan Lacher Vesselin Mitaksov Kristine Wells James Zobel Theodore Oliphant |
| |
Affiliation: | Pfizer Global Research and Development, Chesterfield, Missouri |
| |
Abstract: | Human IgG2 antibodies may exist in at least three distinct structural isomers due to disulfide shuffling within the upper hinge region. Antibody interactions with Fc gamma receptors and the complement component C1q contribute to immune effector functions. These interactions could be impacted by the accessibility and structure of the hinge region. To examine the role structural isomers may have on effector functions, a series of cysteine to serine mutations were made on a human IgG2 backbone. We observed structural homogeneity with these mutants and mapped the locations of their disulfide bonds. Importantly, there was no observed difference in binding to any of the Fc gamma receptors or C1q between the mutants and the wild‐type IgG2. However, differences were seen in the apparent binding affinity of these antibodies that were dependent on the selection of the secondary detection antibody used. |
| |
Keywords: | disulfide isomers disulfide mutants anti‐CD44 mAb human IgG2 Fc gamma receptors C1q effector functions |
|